🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Eligible participants were randomly assigned (1:1:1), using block randomiza...
Status
Unknown
Location
Shanghai Municipal Center for Disease Control and Prevention
Start Date
2023-08
Trial ID
NCT05952505
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
This is a single-center, single-arm, interventional phase I/II trial to eva...
Status
Withdrawn
Location
Masonic Cancer Center - University of Minnesota
Start Date
2024-09
Trial ID
NCT05114837
Treatments Being Tested
Warts can be resistant to treatment or return despite the use of many thera...
Status
Completed
Location
Zagazig university
Start Date
2020-11-20
Trial ID
NCT05254561
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of a...
Status
Completed
Location
Hansa Sanatorium GmbH
Start Date
2016-08-17
Trial ID
NCT02861586
Treatments Being Tested
This is a double-center, single-arm, phase 2 study to evaluate the efficacy...
Status
Recruiting
Location
Dongmei Ji
Start Date
2022-02-26
Trial ID
NCT05257018
Treatments Being Tested
This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-22
Trial ID
NCT00289783
This pilot study will test intra-lesional immunotherapy (MMR vaccine) injec...
Status
Recruiting
Location
Mansoura University Hospital
Start Date
2025-12-09
Trial ID
NCT07312604
Treatments Being Tested
The study is a prospective, single-center, single-arm, two-cohort, phase II...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2022-11-30
Trial ID
NCT05628038
This is an open label, multi-center, phase I/II study to evaluate the effic...
Status
Unknown
Location
Cancer Hospital of Guangzhou Sun Yat-sen University
Start Date
2021-09
Trial ID
NCT05020925